Related Experiment Video
Updated: May 2, 2026

Computed Tomography-guided Time-domain Diffuse Fluorescence Tomography in Small Animals for Localization of Cancer Biomarkers
Published on: July 17, 2012
5-Fluorouracil-Induced Acute Toxic Leukoencephalopathy: A Rare Adverse Effect and Its Early Detection on MRI
Ambar Ambreen1, Muhammad Atif Naveed1, Khalid Javed1
1Radiology, Shaukat Khanum Memorial Cancer Hospital and Research Centre, Lahore, PAK.
Abstract:
This case report discusses a rare occurrence of 5-fluorouracil (5-FU)-induced encephalopathy, an adverse effect of this commonly used antimetabolite and antineoplastic agent. While 5-FU is primarily associated with systemic side effects such as gastrointestinal issues and neutropenia, its cerebral involvement is infrequently documented. Diagnostic imaging techniques, such as computed tomography (CT) and magnetic resonance imaging (MRI), are essential for diagnosing and monitoring this condition. Early recognition and treatment are crucial for a favorable prognosis. We present a case of 5-FU-induced encephalopathy, which was successfully diagnosed based on clinical and MRI findings.
Insights
This case report details a rare instance of 5-fluorouracil (5-FU)-induced encephalopathy. Early diagnosis using MRI and prompt treatment are key for managing this adverse effect of chemotherapy.
Area of Science:
- Neuroscience
- Oncology
- Pharmacology
Background:
- 5-fluorouracil (5-FU) is a widely used antimetabolite and antineoplastic agent.
- Systemic side effects like gastrointestinal issues and neutropenia are common with 5-FU.
- Cerebral involvement, or 5-FU-induced encephalopathy, is a rare but serious adverse effect.
Related Concept Videos
Imaging Studies I: CT and MRI
Description of the Procedures
Computed Tomography (CT) scan:
Computed Tomography (CT) scans use X-ray technology to generate detailed images of bones, organs, and tissues. During the scan, the patient lies on a moving table...
Drug toxicity: Idiosyncratic Reactions
Imaging Studies for Cardiovascular System IV: CMRI

